GLP-1 medications, disordered eating, and the clinical risks Australia isn’t talking about There is a version of the GLP-1 story that is entirely positive. Millions of people with obesity, type 2 diabetes, and cardiovascular disease are experiencing genuine clinical benefit from a class of medications that work in ways previously thought impossible. For many, the […]